UPB

Upstream Bio, Inc. is a clinical-stage biotechnology firm based in Waltham, Massachusetts, dedicated to the advancement of innovative therapies for inflammatory diseases, with a particular emphasis on severe respiratory disorders. The company leverages cutting-edge research and development to address unmet medical needs in this specialty area. With a robust pipeline of therapeutic candidates, Upstream Bio is poised to make significant contributions to the treatment landscape for patients struggling with complex inflammatory conditions.